Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-036856
Filing Date
2026-08-10
Accepted
2026-08-10 16:05:18
Documents
1
Period of Report
2026-08-05

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4980
  Complete submission text file 0001493152-26-036856.txt   6534
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Issuer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address
Morrison James William (Reporting) CIK: 0002137380 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38306 | Film No.: 261258341